(CIDRAP News) The Food and Drug Administration (FDA) issued a regulatory guidance document this week to help spur the development of diagnostic tests for avian influenza in humans.
The document, issued Apr 10, is intended to help medical technology companies meet FDA requirements when developing new tests for influenza A viruses, the FDA said in a Federal Register notice.